Skip to main content

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Entrada Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
4 insiders, $5.92M in total
Insiders trading
4
Net value
−$5.92M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Entrada Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Entrada Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
MPM Bioventures 2018, L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2018 GP LLC10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2018 LLC10% Owner3,885,115IndirectSep 9, 20264
Gadicke Ansbert10% Owner3,885,115IndirectSep 9, 20264
Evnin Luke10% Owner3,885,115IndirectSep 9, 20264
Foley Todd10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014, L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014 (B), L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM Asset Management Investors BV2014 LLC10% Owner3,885,115IndirectSep 9, 20264
MPM Bioventures 2018 (B), L.P.10% Owner3,885,115IndirectSep 9, 20264
MPM Asset Management Investors BV2018 LLC10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014 LLC10% Owner3,885,115IndirectSep 9, 20264
MPM BioVentures 2014 GP LLC10% Owner3,885,115IndirectSep 9, 20264
Doshi DipalCEO517,290Sep 3, 20262
Dowden Nathan JPresident & COO196,060Sep 3, 20264
Sethuraman NatarajanPresident, Research & Develop.214,238Sep 3, 20263
Wentworth Kory JamesChief Financial Officer117,277Sep 3, 20266
Parmar KushDirector2,691,337IndirectAug 10, 20264
Rocklage Scott M10% Owner2,783,781Aug 10, 20263
Schwab Andrew J.10% Owner2,783,781Aug 10, 20263
5AM Ventures V, L.P.10% Owner2,783,781Aug 10, 20263
5AM Opportunities I, L.P.10% Owner2,783,781Aug 10, 20263
5AM Opportunities I (GP), LLC10% Owner2,783,781Aug 10, 20263
5AM Partners V, LLC10% Owner2,783,781Aug 10, 20263
Kim Peter SDirector117,412Jun 12, 20261
Thistle MaryDirector–Jun 12, 20261
Zeiher Bernhardt GDirector5,000IndirectJun 12, 20262
Chapman GinaDirector–Jun 12, 20261
Radhakrishnan MahaDirector–Jun 12, 20261
Baker Julian10% Owner4,691,392IndirectNov 24, 20252
Baker Felix10% Owner4,691,392IndirectNov 24, 20252
Baker Bros. Advisors LP10% Owner4,691,392IndirectNov 24, 20252
Baker Bros. Advisors (GP) LLC10% Owner4,691,392IndirectNov 24, 20252
Kreher NerissaChief Medical Officer40,037Sep 6, 20230
Crowley John FDirector5,000Jun 12, 20230
Nuechterlein CaroleDirector–Jun 6, 20220
Roche Holding Ltd10% Owner2,813,525IndirectNov 4, 20210
Roche Finance Ltd10% Owner2,813,525IndirectNov 4, 20210
Redmile Group, LLC10% Owner1,954,420IndirectNov 4, 20210
Green Jeremy10% Owner1,954,420IndirectNov 4, 20210
Redmile Biopharma Investments III, L.P.10% Owner1,954,420IndirectNov 4, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 4, 2021 (view filing)Nov 22 daysFoley ToddDirector, 10% OwnerPPurchase+100.0K$20.00+$2.00M+2.3%4.43M after
Nov 4, 2021 (view filing)5:37 PM ETNov 22 daysGadicke Ansbert and 8 others10% OwnerPPurchase+100.0K$20.00+$2.00M+2.3%4.43M afterDuplicate filing
Nov 4, 2021 (view filing)5:38 PM ETNov 22 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerPPurchase+100.0K$20.00+$2.00M+2.3%4.43M afterDuplicate filing
Nov 4, 2021 (view filing)9:00 PM ETNov 22 daysRedmile Group, LLC and 2 others10% OwnerPPurchase+1.00M$20.00+$20.0M+104.8%1.95M after
Nov 4, 2021 (view filing)9:10 PM ETNov 22 daysRocklage Scott M and 5 others10% OwnerPPurchase+250.0K$20.00+$5.00M+28.3%1.13M after
Nov 5, 2021 (view filing)Nov 23 daysLateParmar KushDirector, 10% OwnerPPurchase+250.0K$20.00+$5.00M+28.3%1.13M afterDuplicate filing
Jan 13, 2022 (view filing)Jan 121 dayCrowley John FDirectorPPurchase+5.00K$9.72+$48.6KNew position5.00K after
May 18, 2022 (view filing)5:38 PM ETMay 16-182 daysBaker Julian and 3 others10% OwnerPPurchase+71.9K$5.99+$430.7K+1.7%4.42M after8 lots
May 24, 2022 (view filing)6:39 PM ETMay 20-244 daysBaker Julian and 3 others10% OwnerPPurchase+48.5K$5.82+$282.4K+1.1%4.47M after10 lots
Jun 6, 2022 (view filing)5:07 PM ETJun 2-64 daysBaker Julian and 3 others10% OwnerPPurchase+40.9K$6.37+$260.8K+0.9%4.50M after6 lots
Jun 29, 2022 (view filing)Jun 272 daysDoshi DipalPresident and CEOSSale−4.00K$12.00−$48.0K−1.9%210.7K after
Jun 29, 2022 (view filing)Jun 272 daysDowden Nathan JChief Operating OfficerSSale−7.71K$13.00−$100.3K−10.6%64.9K after
Jul 29, 2022 (view filing)Jul 272 daysDoshi DipalPresident and CEOSSale−2.00K$12.00−$24.0K−0.9%208.7K after
Aug 18, 2022 (view filing)Aug 16-182 daysWentworth Kory JamesChief Financial OfficerSSale−600$13.02−$7.81K−2.9%20.2K after3 lots
Aug 23, 2022 (view filing)Aug 19-234 daysWentworth Kory JamesChief Financial OfficerSSale−11.7K$13.08−$152.5K−44.5%14.5K after3 lots
Aug 26, 2022 (view filing)Aug 24-252 daysWentworth Kory JamesChief Financial OfficerSSale−4.67K$13.79−$64.4K−29.8%11.0K after3 lots
Aug 31, 2022 (view filing)Aug 29-312 daysDoshi DipalPresident and CEOSSale−2.00K$12.72−$25.4K−1.0%206.7K after5 lots
Sep 12, 2022 (view filing)Sep 8-94 daysDowden Nathan JChief Operating OfficerSSale−1.78K$15.11−$26.8K−2.5%68.7K after2 lots
Sep 12, 2022 (view filing)Sep 8-94 daysKreher NerissaChief Medical OfficerSSale−2.02K$15.11−$30.5K−8.9%20.7K after2 lots
Sep 12, 2022 (view filing)Sep 8-94 daysDoshi DipalPresident and CEOSSale−1.79K$15.13−$27.0K−0.8%220.0K after2 lots
Sep 19, 2022 (view filing)Sep 154 daysKreher NerissaChief Medical OfficerSSale−106$15.01−$1.59K−0.5%20.7K after
Sep 19, 2022 (view filing)Sep 154 daysDowden Nathan JChief Operating OfficerSSale−100$15.01−$1.50K−0.1%68.6K after
Sep 19, 2022 (view filing)Sep 154 daysDoshi DipalPresident and CEOSSale−200$15.04−$3.01K−0.1%219.8K after
Sep 23, 2022 (view filing)Sep 21-232 daysDowden Nathan JChief Operating OfficerSSale−4.29K$15.12−$64.9K−6.3%64.4K after2 lots
Sep 23, 2022 (view filing)Sep 21-232 daysKreher NerissaChief Medical OfficerSSale−4.28K$15.08−$64.6K−17.1%20.7K after2 lots
Sep 23, 2022 (view filing)Sep 21-232 daysDoshi DipalPresident and CEOSSale−4.42K$15.11−$66.9K−2.0%215.4K after2 lots
Sep 28, 2022 (view filing)Sep 262 daysDowden Nathan JChief Operating OfficerSSale−1.54K$15.45−$23.9K−2.4%62.8K after2 lots
Sep 28, 2022 (view filing)Sep 26-282 daysKreher NerissaChief Medical OfficerSSale−8.59K$15.29−$131.4K−29.3%20.7K after4 lots
Sep 28, 2022 (view filing)Sep 26-282 daysDoshi DipalPresident and CEOSSale−10.6K$15.25−$161.4K−4.9%204.8K after5 lots
Oct 24, 2022 (view filing)Oct 20-244 daysDoshi DipalPresident and CEOSSale−5.94K$18.64−$110.7K−2.9%198.9K after4 lots
Oct 24, 2022 (view filing)Oct 20-244 daysDowden Nathan JChief Operating OfficerSSale−6.08K$18.66−$113.4K−9.7%56.7K after4 lots
Oct 27, 2022 (view filing)Oct 25-272 daysDoshi DipalPresident and CEOSSale−14.1K$20.80−$292.5K−7.1%184.8K after4 lots
Oct 27, 2022 (view filing)Oct 252 daysDowden Nathan JChief Operating OfficerSSale−9.35K$20.77−$194.2K−16.5%47.4K after3 lots
Oct 27, 2022 (view filing)Oct 25-262 daysKreher NerissaChief Medical OfficerSSale−13.0K$21.27−$276.5K−38.6%20.7K after5 lots
Nov 2, 2022 (view filing)Oct 312 daysDowden Nathan JChief Operating OfficerSSale−2.10K$24.05−$50.5K−4.4%45.3K after
Nov 18, 2022 (view filing)Nov 162 daysWentworth Kory JamesChief Financial OfficerSSale−200$18.10−$3.62K−1.2%16.5K after
Nov 30, 2022 (view filing)Nov 282 daysDoshi DipalPresident and CEOSSale−2.00K$13.91−$27.8K−1.1%182.8K after
Dec 6, 2022 (view filing)Dec 2-54 daysWentworth Kory JamesChief Financial OfficerSSale−3.11K$18.19−$56.6K−15.9%16.5K after2 lots
Dec 12, 2022 (view filing)Dec 84 daysWentworth Kory JamesChief Financial OfficerSSale−4.55K$18.95−$86.2K−21.6%16.5K after
Dec 29, 2022 (view filing)Dec 27-292 daysDoshi DipalPresident and CEOSSale−14.6K$15.02−$219.1K−8.0%168.2K after4 lots
Jan 3, 2023 (view filing)Dec 30, 20224 daysKreher NerissaChief Medical OfficerSSale−5.20K$13.45−$69.9K−25.1%15.5K after
Jan 10, 2023 (view filing)Jan 91 dayDoshi DipalPresident and CEOSSale−2.41K$15.02−$36.2K−1.4%165.8K after
Jan 30, 2023 (view filing)Jan 273 daysDoshi DipalPresident and CEOSSale−2.00K$12.00−$24.0K−1.2%163.8K after
Mar 2, 2023 (view filing)Feb 282 daysDoshi DipalPresident and CEOSSale−2.00K$12.00−$24.0K−1.2%161.8K after
Mar 3, 2023 (view filing)Mar 21 dayKreher NerissaChief Medical OfficerSSale−1.64K$10.56−$17.3K−3.8%41.3K afterFrom original2 lots
Mar 3, 2023 (view filing)Mar 21 dayWentworth Kory JamesChief Financial OfficerSSale−1.75K$10.52−$18.4K−4.0%42.2K afterFrom original2 lots
Mar 29, 2023 (view filing)Mar 272 daysDoshi DipalPresident and CEOSSale−2.00K$14.72−$29.4K−0.8%255.8K after2 lots10b5-1
Apr 19, 2023 (view filing)Apr 172 daysSethuraman NatarajanChief Scientific OfficerSSale−3.96K$18.00−$71.3K−2.3%171.3K after10b5-1
Apr 19, 2023 (view filing)Apr 172 daysDoshi DipalPresident and CEOSSale−2.09K$18.01−$37.7K−1.0%204.1K after10b5-1
May 1, 2023 (view filing)Apr 274 daysDoshi DipalPresident and CEOSSale−2.00K$13.71−$27.4K−1.0%202.1K after10b5-1